Amplia Therapeutics Ltd. (AU:ATX) has released an update.
Amplia Therapeutics Limited has issued an update announcing a change in the holdings of Director Jane Bell, who has acquired additional shares in the company. The change, part of an entitlement offer, reflects an increased direct interest in the pharmaceutical company that is focused on developing FAK inhibitors for cancer and fibrosis treatments.
For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.
